SCHEMBL6515524

SCHEMBL6515524

[NH]S(=O)(=O)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.64
HTT P42858 4/20 0.58
LMNA P02545 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
CA9 Q16790 2/20 0.53
TSHR P16473 2/20 0.52
LTA4H P09960 1/20 0.52
PGR P06401 5/20 0.52
MMP1 P03956 2/20 0.51
MMP3 P08254 2/20 0.51
MMP8 P22894 2/20 0.51
MMP13 P45452 1/20 0.51
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
MAPT P10636 1/20 0.50
XBP1 P17861 1/20 0.50
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1133806 0.83 SOS1 (0.64) SOS1HTTLMNASMN1; SMN2CA1
SCHEMBL17559302 0.82 HTT (0.81) SOS1HTTLMNASMN1; SMN2CA1
SCHEMBL11415437 0.82 HTT (0.81) SOS1HTTLMNASMN1; SMN2CA1
SCHEMBL6123058 0.82 HTT (0.81) SOS1HTTLMNASMN1; SMN2CA1
SCHEMBL146566 0.82 HTT (0.81) SOS1HTTLMNASMN1; SMN2CA1
SCHEMBL1462245 0.81 SOS1 (0.62) SOS1HTTLMNASMN1; SMN2CA1
Hydrochloric Acid SCHEMBL28805909 0.81 SOS1 (0.62) SOS1HTTLMNASMN1; SMN2CA1
SCHEMBL9323430 0.80 HTT (0.78) SOS1HTTLMNASMN1; SMN2CA1
Diphenylether SCHEMBL387430 0.79 LTA4H (0.67) SOS1HTTLMNASMN1; SMN2CA1
Diphenylether SCHEMBL8662108 0.79 LTA4H (0.67) SOS1HTTLMNASMN1; SMN2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137234-A1 Histone deacetylase inhibitors HDAC1, HDAC5, HDAC11 SOS1 3608/4885HTT 3356/4885LMNA 680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.